38
Views
2
CrossRef citations to date
0
Altmetric
Original Article

Characterization of ‘Winners’ to Enoxaparin in the Prevention of Postoperative Venous Thromboembolism in Digestive Surgery

, , , , , , & show all
Pages 616-621 | Received 02 Jun 1995, Accepted 16 Nov 1995, Published online: 08 Jul 2009
 

Abstract

Background: A total of 826 patients were included in three ‘play-the-winner’ studies to investigate the safety of prophylaxis against venous thromboembolism in digestive surgery. To characterize patients benefiting from prophylaxis with low-molecular heparin, the 445 patients allocated to enoxaparin were investigated. Methods: A training set consisting of 292 patients from 2 of the studies was analysed by using a linear discriminant model. The reliability of the results was verified on a test set consisting of 153 patients from the third study. Results: A typical ‘winner’ was a young patient, preferably female, with serum bilirubin in the lower normal range, combined with body temperature, serum sodium, creatinine, and albumin in the upper normal ranges. By using the discriminant function on the test set, 81.7% of the ‘winners’ and 21.1% of the ‘losers’ were correctly classified. Conclusion: The discriminant function for characterization of winners to enoxaparin was found adequate. No rule was acceptable for characterization of losers.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.